Trichinella spiralis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 23: Line 23:
*Trichinella spiralis<ref name="pmid19136437">{{cite journal| author=Gottstein B, Pozio E, Nöckler K| title=Epidemiology, diagnosis, treatment, and control of trichinellosis. | journal=Clin Microbiol Rev | year= 2009 | volume= 22 | issue= 1 | pages= 127-45, Table of Contents | pmid=19136437 | doi=10.1128/CMR.00026-08 | pmc=PMC2620635 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19136437  }} </ref>
*Trichinella spiralis<ref name="pmid19136437">{{cite journal| author=Gottstein B, Pozio E, Nöckler K| title=Epidemiology, diagnosis, treatment, and control of trichinellosis. | journal=Clin Microbiol Rev | year= 2009 | volume= 22 | issue= 1 | pages= 127-45, Table of Contents | pmid=19136437 | doi=10.1128/CMR.00026-08 | pmc=PMC2620635 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19136437  }} </ref>


:*Preferred regimen: [[Albendazole]] 400 mg PO bid for 8 to 14 days {{or}} [[Mebendazole]] 200 to 400 mg PO tid for 3 days, then 400 to 500 mg PO tid for 10 days
:*Preferred regimen: [[Albendazole]] 400 mg PO bid for 8-14 days {{or}} [[Mebendazole]] 200-400 mg PO tid for 3 days {{then}} 400-500 mg PO tid for 10 days
:*Note(1): Albendazole and Mebendazole are contraindicated during pregnancy and not recommended in children aged 2 years.
:*Note(1): Albendazole and Mebendazole are contraindicated during pregnancy and not recommended in children aged 2 years.
:*Note(2): prednisone administered at a dose of 30 mg/day to 60 mg/day for 10 to 15 days for severe symptoms
:*Note(2): prednisone administered at a dose of 30 mg/day to 60 mg/day for 10 to 15 days for severe symptoms

Revision as of 14:14, 27 July 2015

style="background:#Template:Taxobox colour;"|Whipworm
style="background:#Template:Taxobox colour;" | Scientific classification
Kingdom: Animalia
Phylum: Nematoda
Class: Adenophorea
Order: Trichurida
Family: Trichinellidae
Genus: Trichinella
Species: T. spiralis
Binomial name
Trichinella spiralis
(Owen, 1835)

The species Trichinella spiralis is an important parasite, occurring in rats, pigs, and humans, and is responsible for the disease trichinosis. It is sometimes referred to as the "pork worm" due to it being found commonly in pork products that are undercooked.

Description

The small adult worms mature in the intestine of an intermediate host such as a pig. Each adult female produces batches of live larvae, which bore through the intestinal wall, enter the blood (to feed on it) and lymphatic system, and are carried to striated muscle tissue. Once in the muscle, they encyst, or become enclosed in a capsule.

Life cycle

Larvae encysted in the muscles remain viable for some time. When the muscle tissue is eaten by a human, the cysts are digested in the stomach; the released larvae migrate to the intestine to begin a new life cycle. Female trichina worms live about six weeks and in that time may release larvae. The migration and encystment of larvae can cause fever, pain, and even death because of their potential to eat living tissue. One of the classic signs of Trichinella spiralis infection is a combination of splinter hemorrhages (not to be confused with those of bacterial endocarditis) and periorbital edema (eye swelling). Trichina are classified in the phylum Nematoda.

Treatment

Antimicrobial Regimen

  • Trichinella spiralis[1]
  • Preferred regimen: Albendazole 400 mg PO bid for 8-14 days OR Mebendazole 200-400 mg PO tid for 3 days THEN 400-500 mg PO tid for 10 days
  • Note(1): Albendazole and Mebendazole are contraindicated during pregnancy and not recommended in children aged 2 years.
  • Note(2): prednisone administered at a dose of 30 mg/day to 60 mg/day for 10 to 15 days for severe symptoms

External links

References

  1. Gottstein B, Pozio E, Nöckler K (2009). "Epidemiology, diagnosis, treatment, and control of trichinellosis". Clin Microbiol Rev. 22 (1): 127–45, Table of Contents. doi:10.1128/CMR.00026-08. PMC 2620635. PMID 19136437.